CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,935,394 | +22.7% | 99,640 | +35.9% | 0.00% | +33.3% |
| Q2 2023 | $2,392,449 | -8.1% | 73,343 | -0.8% | 0.00% | 0.0% |
| Q1 2023 | $2,602,054 | +11.0% | 73,943 | +44.6% | 0.00% | 0.0% |
| Q4 2022 | $2,343,372 | +24.3% | 51,143 | +32.7% | 0.00% | +50.0% |
| Q3 2022 | $1,886,000 | +60.4% | 38,543 | +28.7% | 0.00% | +100.0% |
| Q2 2022 | $1,176,000 | +4.7% | 29,943 | -1.8% | 0.00% | 0.0% |
| Q1 2022 | $1,123,000 | +193.2% | 30,500 | +263.1% | 0.00% | – |
| Q4 2021 | $383,000 | -50.5% | 8,400 | -76.5% | 0.00% | -100.0% |
| Q3 2020 | $773,000 | +418.8% | 35,700 | +95.1% | 0.00% | – |
| Q4 2017 | $149,000 | -43.8% | 18,300 | 0.0% | 0.00% | – |
| Q3 2017 | $265,000 | +85.3% | 18,300 | -3.0% | 0.00% | – |
| Q3 2013 | $143,000 | – | 18,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |